References
- CaiJZhuPZhangCDetection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomasOncotarget2016713163841639526918938
- DolecekTAProppJMStroupNEKruchkoCCBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009Neuro Oncol201214Suppl 5v14923095881
- StuppRMasonWPvan den BentMJEuropean Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy GroupsNational Cancer Institute of Canada Clinical Trials GroupRadiotherapy plus concomitant and adjuvant temozolomide for glioblastomaN Engl J Med20053521098799615758009
- Van MeirEGHadjipanayisCGNordenADShuHKWenPYOlsonJJExciting new advances in neuro-oncology: the avenue to a cure for malignant gliomaCA Cancer J Clin201060316619320445000
- LiQJCaiJQLiuCYEvolving molecular genetics of glioblastomaChin Med J (Engl)2016129446447126879021
- JozwikKMCarrollJSPioneer factors in hormone-dependent cancersNat Rev Cancer201212638138522555282
- BochkisIMRubinsNEWhitePFurthEEFriedmanJRKaestnerKHHepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stressNat Med200814882883618660816
- BernardoGMKeriRAFOXA1: a transcription factor with parallel functions in development and cancerBiosci Rep201232211313022115363
- FriedmanJRKaestnerKHThe Foxa family of transcription factors in development and metabolismCell Mol Life Sci20066319–202317232816909212
- KaestnerKHThe FoxA factors in organogenesis and differentiationCurr Opin Genet Dev201020552753220591647
- AugelloMAHickeyTEKnudsenKEFOXA1: master of steroid receptor function in cancerEMBO J201130193885389421934649
- CarrollJSLiuXSBrodskyASChromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1Cell20051221334316009131
- WangLLXiuYLChenXThe transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progressionTumour Biol2017395 1010428317706210
- WangLQinHLiLForkhead-box A1 transcription factor is a novel adverse prognosis marker in human gliomaJ Clin Neurosci201320565465823510544
- KnudsenKEDiehlJAHaimanCAKnudsenESCyclin D1: polymorphism, aberrant splicing and cancer riskOncogene200625111620162816550162
- BrennanPHainautPBoffettaPGenetics of lung-cancer susceptibilityLancet Oncol201112439940820951091
- FuXJLiHXYangKChenDTangHThe important tumor suppressor role of PER1 in regulating the cyclin-CDK-CKI network in SCC15 human oral squamous cell carcinoma cellsOnco Targets Ther201692237224527143919
- LeeBSandhuSMcArthurGCell cycle control as a promising target in melanomaCurr Opin Oncol201527214115025588041
- LiuYNLeeWWWangCYChaoTHChenYChenJHRegulatory mechanisms controlling human E-cadherin gene expressionOncogene200524568277829016116478
- CheneyIWNeuteboomSTVaillancourtMTRamachandraMBook-steinRAdenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexesCancer Res199959102318232310344736
- KaldisPAleemECell cycle sibling rivalry: Cdc2 vs. Cdk2Cell cycle20054111491149416258277